Gregory Everson

Gregory Everson

Company: Hepquant

Job title: Chief Executive Officer & Founder

Seminars:

The HepQuant Liver Function Test to Enhance Drug Development 11:30 am

Experience in monitoring liver function in clinical trial Update on Regulatory path and results of pivotal study New developments on the horizonRead more

day: Day 1 Stream 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.